Methylphenidate-induced changes in cerebral hemodynamics measured by functional near-infrared spectroscopy

Journal of Child Neurology

Volumn 22, Issue 7, 2007, Pages 812-817

  Weber, Peter ^a   Lütschg, Jürg ^a   Fahnenstich, Hubert ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Department of Pediatrics   (Germany)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Functional near infrared spectroscopy; Methylphenidate

Indexed keywords

DEOXYHEMOGLOBIN; HEMOGLOBIN; METHYLPHENIDATE; OXYHEMOGLOBIN;

ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN OXYGEN CONSUMPTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG DOSE INCREASE; DRUG EXPOSURE; FEASIBILITY STUDY; HEMODYNAMIC MONITORING; HUMAN; MALE; NEAR INFRARED SPECTROSCOPY; PHARMACOLOGICAL PARAMETERS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SCHOOL CHILD; SENSITIVITY ANALYSIS; TISSUE OXYGENATION;

AROUSAL; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBROVASCULAR CIRCULATION; CHILD; FUNCTIONAL LATERALITY; HUMANS; MALE; METHYLPHENIDATE; PREFRONTAL CORTEX; SPECTROSCOPY, NEAR-INFRARED;

EID: 34547893447     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807304197     Document Type: Article

References (46)

1. Roth RM, Saykin AJ Executive dysfunction in attention-deficit/ hyperactivity disorder: Cognitive and neuroimaging findings. Psychiatr Clin North Am. 2004;27:83-96.
2. Solanto MV Neuropsychopharmacological mechanism of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behav Brain Res. 1998;94:127-152.
3. Solanto MV Dopamine dysfunction in AD/HD: Integrating clinical and basic neuroscience research. Behav Brain Res. 2002;130:65-71.
4. Obrig H., Villringer A. Beyond the visible-imaging the human brain with light. J Cereb Blood Flow Metab. 2003;23:1-18.
5. Villringer A., Chance B. Non-invasive optical spectroscopy and imaging of human brain function. TINS. 1997;20:435-442.
6. Barkley RA ADHD and the Nature of Self-Control. New York: Guilford Press; 1997.
7. Sonuga-Barke EJ The dual pathway model of AD/HD: An elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev. 2003;27:593-604.
8. Feron FJ, Hendriksen JG, van Kroonenburgh MJ, et al. Dopamine transporter in attention-deficit hyperactivity disorder normalizes after cessation of methylphenidate. Pediatr Neurol. 2005;33:179-183.
9. Krause KH, Dresel SH, Krause J., et al. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett. 2000;285:107-110.
10. Krause J., Fougere la C., Krause KH, et al. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. Eur Arch Psychiatry Clin Neurosci. 2005;255:428-431.
11. Rosa-Neto P., Lou H., Cumming P., et al. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage. 2005;25:868-876.
12. Conners CK Forty years of methylphenidate treatment in attention-deficit/ hyperactivity disorder. J Atten Disord. 2002;6(suppl1):S17-S30.
13. Lee JS, Kim BN, Kang E., et al. Regional cerebral blood flow in children with attention deficit hyperactivity disorder: Comparison before and after methylphenidate treatment. Hum Brain Mapp. 2005;24:157-164.
14. Kim BN, Lee JS, Shin MS, et al. Regional cerebral perfusion abnormalities in attention deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci. 2002;252:219-225.
15. Vaidya CJ, Austin G., Kirkorian G., et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proc Natl Acad Sci U S A. 1998;95:14494-14499.
16. Schweitzer JB, Lee DO, Hanford RB, et al. A positron emission tomography study of methylphenidate in adults with ADHD: Alterations in resting blood flow and predicting treatment response. Neuropsychopharmacology. 2003;28:967-973.
17. Shafritz KM, Marchione KE, Gore JC, et al. The effect of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. Am J Psychiatry. 2004;161:1990-1997.
18. Szobot C., Ketzer C., Cunha RD, et al. The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/ hyperactivity disorder. Eur J Nucl Med Mol Imaging. 2003;30:423-426.
19. Schweitzer JB, Lee DO, Hanford RB, et al. Effects of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: Normalization of behaviour but not related brain activity. Biol Psychiatry. 2004;56:597-606.
20. Mehta MA, Owen AM, Sahakian BJ, et al. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 2000;20:RC65.
21. Weber P., Lütschg J., Fahnenstich H. Cerebral hemodynamic changes in response to an executive function task in children with attention deficit disorder measured by near-infrared spectroscopy. J Dev Behav Pediatr. 2005;26:105-111.
22. American Psychiatric Association. DSM IV: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994.
23. Conners CK Conners' Rating Scales-Revised. Technical Manual. New York: MHS; 2001.
24. Raven JC, Raven J., Court JH Raven's Progressive Matrices-CPM Manual German ed. Frankfurt: Swets & Zeitlinger; 2002.
25. Raven JC Standard Progressive Matrices-SPM Manual. German ed. Göttingen: Beltz; 1998.
26. Barkley RA Attention-Deficit Hyperactivity Disorder. A Handbook for Diagnosis and Treatment. 2nd ed. New York: Guilford Press; 1998.
27. Oswald WD, Roth E. Zahlenverbindungstest (Trail-making test). 2 nd ed. Göttingen: Hogrefe; 1997.
28. Willcutt EG, Doyle AE, Nigg JT, et al. Validity of the executive function theory of the attention deficit/hyperactivity disorder: A meta-analytic review. Biol Psychiatry. 2005;57:1336-1346.
29. Shue KL, Douglas VI Attention deficit hyperactivity disorder and frontal lobe syndrome. Brain Cogn. 1992;20:104-124.
30. Bölte S., Adam-Schwebe S., Englert E., et al. Zur Praxis der psychologischen Testdiagnostik in der deutschen Kinder- und J Jugendpsychiatrie: Ergebnisse einer Umfrage. Z Kinder Jugendpsychiatr Psychother. 2000;28:151-161.
31. Rabin LA, Barr WB, Burton LA Assessment practices of clinical neuropsychologists in the United States and Canada: A survey of INS, NAN, and APA Division 40 members. Arch Clin Neuropsychol. 2005;20:33-65.
32. Segalowitz SJ, Unsal A., Dywan J. CNV evidence for the distinctiveness of frontal and posterior processes in a traumatic-brain injured population. J Clin Exp Neuropsychol. 1992;14:545-565.
33. Moll J., Oliveira-Souza RR, Moll FT, et al. The cerebral correlates of set-shifting: An fMRI study of the trail making test. Arq Neuropsiquiatr. 2002;60:900-905.
34. Moser DJ, Jorge RE, Manes F., et al. Improved executive functioning following repetitive transcranial magnetic stimulation. Neurology. 2002;58:1288-1290.
35. Zakzanis KK, Mraz R., Graham SJ An fMRI study of the trail making test. Neuropsychologia. 2005;43:1878-1886.
36. Homan RW, Herman J., Purdy P. Cerebral location of international 10-20 system electrode placement. Electroencephalogr Clin Neurophysiol. 1987;66:376-382.
37. Weber P., Lütschg J., Fahnenstich H. Attention-induced frontal brain activation measured by near-infrared spectroscopy. Pediatr Neurol. 2004;31:96-100.
38. Anderson CM, Polcari A., Lowen SB, et al. Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD. Am J Psychiatry. 2002;159:1322-1328.
39. Krimer LS, Muly C., Williams GV, Goldman-Rakic PS Dopaminergic regulation of cerebral cortical microcirculation. Nat Neurosci. 1998;1:286-289.
40. Rao SM, Salmeron BJ, Durgerian S., et al. Effects of methylphenidate on functional MRI blood-oxygen-level-dependent contrast. Am J Psychiatry. 2000;157:1697-1699.
41. Matochik JA, Nordahl TE, Gross M., et al. Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychophamacology. 1993;8:377-386.
42. Brun NC, Moen A., Borch K., et al. Near-infrared monitoring of cerebral tissue oxygen saturation and blood volume in newborn piglets. Am J Physiol. 1997;273:H682-H686.
43. Skov L., Pryds O., Greisen G., Lou H. Estimation of cerebral venous saturation in newborn infants by near infrared spectroscopy. Pediatr Res. 1993,33:52-55.
44. Quaresima V., Sacco S., Totaro R., Ferrari M. Noninvasive measurement of cerebral hemoglobin oxygen saturation using two near infrared spectroscopy approaches. J Biomed Opt. 2000;5:201-205.
45. Sato H., Fuchino Y., Kiguchi M., et al. Intersubject variability of near-infrared spectroscopy signals during sensorimotor cortex activation. J Biomed Opt. 2005;10:44001.
46. Schroeter ML, Zysset S., Wahl M., von Cramon DY. Prefrontal activation due to Stroop interference increases during development- an event-related fNIRS study. Neuroimaging. 2004;23:1317-1327.